TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 1 | -2 | -21 | -36 | -28 | -77 | -27 |
| S | %wins | 50 | 100 | 100 | 50 | 50 | 100 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/18/14 19:23 | 3/14/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wyrick Susan D. | WA | O | PAO | M.d | 0 | 0.00 | 4 | 1 | 65 | 1 | D | -21 | 1 | 35 | 53 | 16 | 9 | 0 | -5 | -1 | -1 | -23 | -76 | -80 | -86 |
3/18/14 19:23 | 3/17/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wyrick Susan D. | WA | O | PAO | S.d | -2 | 12.25 | 4 | 0 | -12 | 1 | D | -21 | 1 | 35 | 53 | 16 | 9 | 0 | -5 | -1 | -1 | -23 | -76 | -80 | -86 |
10/3/13 20:11 | 8/19/13 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wyrick Susan D. | WA | O | PAO | S.adm | -3 | 8.86 | 1 | 0 | -28 | 1 | D | -8 | -37 | -15 | -4 | 2 | 0 | -1 | -2 | 3 | -2 | -18 | 4 | 24 | -68 |
10/3/13 20:11 | 10/1/13 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wyrick Susan D. | WA | O | PAO | M.ad | 0 | 0.00 | 1 | 1 | 237 | 1 | D | -8 | -37 | -15 | -4 | 2 | 0 | -1 | -2 | 3 | -2 | -18 | 4 | 24 | -68 |
8/15/13 18:13 | 8/13/13 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wyrick Susan D. | WA | O | PAO | M.d | 0 | 0.00 | 1 | 1 | 1 | D | -21 | -36 | -23 | -9 | -1 | -8 | -5 | -1 | 0 | -1 | 3 | -19 | 31 | -61 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |